Optimal survival analyses with prevalent and incident patients

被引:0
|
作者
Hartman, Nicholas [1 ]
机构
[1] Univ Michigan, Dept Biostat, 1415 Washington Hts, Ann Arbor, MI 48109 USA
关键词
Cox Proportional Hazards Model; Epidemiology; Kaplan-Meier; Left truncation; Study design; NONPARAMETRIC-ESTIMATION; COHORT; ESTIMATOR; MORTALITY;
D O I
10.1007/s10985-024-09639-6
中图分类号
O1 [数学];
学科分类号
0701 ; 070101 ;
摘要
Period-prevalent cohorts are often used for their cost-saving potential in epidemiological studies of survival outcomes. Under this design, prevalent patients allow for evaluations of long-term survival outcomes without the need for long follow-up, whereas incident patients allow for evaluations of short-term survival outcomes without the issue of left-truncation. In most period-prevalent survival analyses from the existing literature, patients have been recruited to achieve an overall sample size, with little attention given to the relative frequencies of prevalent and incident patients and their statistical implications. Furthermore, there are no existing methods available to rigorously quantify the impact of these relative frequencies on estimation and inference and incorporate this information into study design strategies. To address these gaps, we develop an approach to identify the optimal mix of prevalent and incident patients that maximizes precision over the entire estimated survival curve, subject to a flexible weighting scheme. In addition, we prove that inference based on the weighted log-rank test or Cox proportional hazards model is most powerful with an entirely prevalent or incident cohort, and we derive theoretical formulas to determine the optimal choice. Simulations confirm the validity of the proposed optimization criteria and show that substantial efficiency gains can be achieved by recruiting the optimal mix of prevalent and incident patients. The proposed methods are applied to assess waitlist outcomes among kidney transplant candidates.
引用
收藏
页码:24 / 51
页数:28
相关论文
共 50 条
  • [31] Survival analysis in the incident dialysis patients by different modalities
    Lv, Wenlv
    Chen, Xiaohong
    Wang, Yaqiong
    Yu, Jiawei
    Cao, Xuesen
    Ding, Xiaoqiang
    Zou, Jianzhou
    Shen, Bo
    Nie, Yuxin
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2021, 44 (11): : 816 - 821
  • [32] THE INTERACTIONS AND ASSOCIATIONS WITH SURVIVAL OF MALNUTRITION, INFLAMMATION AND OVERHYDRATION IN PREVALENT HEMODIALYSIS PATIENTS
    Dekker, Marijke
    Konings, Constantijn
    Canaud, Bernard
    van der Sande, Frank
    Raimann, Jochen
    Usvyat, Len
    Kotanko, Peter
    Kooman, Jeroen
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32
  • [33] Net Survival in Survival Analyses for Patients with Cancer: A Scoping Review
    Lima Nagamine, Camila Macedo
    Garcia de Goulart, Barbara Niegia
    Ziegelmann, Patricia Klarmann
    CANCERS, 2022, 14 (14)
  • [34] Thyroid Disease Is Prevalent and Predicts Survival in Patients With Idiopathic Pulmonary Fibrosis
    Oldham, Justin M.
    Kumar, Disha
    Lee, Cathryn
    Patel, Shruti B.
    Takahashi-Manns, Stephenie
    Demchuk, Carley
    Strek, Mary E.
    Noth, Imre
    CHEST, 2015, 148 (03) : 692 - 700
  • [35] Serum trace metal association with response to erythropoiesis stimulating agents in incident and prevalent hemodialysis patients
    Michael E. Brier
    Jessica R. Gooding
    James M. Harrington
    Jason P. Burgess
    Susan L. McRitchie
    Xiaolan Zhang
    Brad H. Rovin
    Jon B. Klein
    Jonathan Himmelfarb
    Susan J. Sumner
    Michael L. Merchant
    Scientific Reports, 10
  • [36] Prevalent vs Incident Screen: Why Does It Matter?
    Hayward, Jessica H.
    Lee, Amie Y.
    Sickles, Edward A.
    Ray, Kimberly M.
    JOURNAL OF BREAST IMAGING, 2024, 6 (03) : 232 - 237
  • [37] Cardiovascular risks associated with incident and prevalent periodontal disease
    Yu, Yau-Hua
    Chasman, Daniel I.
    Buring, Julie E.
    Rose, Lynda
    Ridker, Paul M.
    JOURNAL OF CLINICAL PERIODONTOLOGY, 2015, 42 (01) : 21 - 28
  • [38] Incident Cancer Risk of Patients with Prevalent Type 2 Diabetes Mellitus in Hungary (Part 2)
    Abonyi-Toth, Zsolt
    Rokszin, Gyorgy
    Suto, Gabor
    Fabian, Ibolya
    Kiss, Zoltan
    Jermendy, Gyorgy
    Kempler, Peter
    Lengyel, Csaba
    Wittmann, Istvan
    Molnar, Gergo A.
    CANCERS, 2024, 16 (13)
  • [39] Serum trace metal association with response to erythropoiesis stimulating agents in incident and prevalent hemodialysis patients
    Brier, Michael E.
    Gooding, Jessica R.
    Harrington, James M.
    Burgess, Jason P.
    McRitchie, Susan L.
    Zhang, Xiaolan
    Rovin, Brad H.
    Klein, Jon B.
    Himmelfarb, Jonathan
    Sumner, Susan J.
    Merchant, Michael L.
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [40] Predictive modeling for incident and prevalent diabetes risk evaluation
    Masconi, Katya L.
    Echouffo-Tcheugui, Justin Basile
    Matsha, Tandi E.
    Erasmus, Rajiv T.
    Kengne, Andre Pascal
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2015, 10 (03) : 277 - 284